Cafepharma Today

May 14 2025 - AbbVie pays ADARx $335M cash for next-gen siRNA options
AbbVie pays ADARx $335M cash for next-gen siRNA options
Novo Nordisk inks $2.2B deal for Septerna's preclinical obesity programs
Roche reports final overall survival outcomes from breast cancer treatment trial
GSK buys phase III–ready liver drug in potential $2B deal to play in MASH arena
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Teva out-grows Big Pharma in IMS ranking
Fierce Pharma
Monday, March 29, 2010 - 10:43am
tags:
Teva Pharmaceuticals, pharma industry, IMS
Law puts small doc payments up for disclosure
Fierce Pharma
Monday, March 29, 2010 - 10:39am
tags:
physicial payments
Lesson From Pfizer: Don't Describe Your Product as "Snake Oil" in Internal Email
BNET Pharma
Monday, March 29, 2010 - 10:34am
tags:
Pfizer, Neurontin
Isis rises on breast cancer study
Marketwatch
Monday, March 29, 2010 - 10:29am
tags:
breast cancer, Isis Pharmaceuticals
Antisoma plunges as late-stage lung-cancer-drug trial halted
Marketwatch
Monday, March 29, 2010 - 10:14am
tags:
Antisoma, lung cancer
Biogen, Merck, Bayer MS Drugs Targeted by Test Predicting Which Ones Work
Bloomberg
Monday, March 29, 2010 - 10:09am
tags:
Biogen Idec, Merck, Bayer, MS, multiple sclerosis
Avid Radiopharmaceuticals, Cardinal Health Reach Milestone In Alzheimer's Research
Medical News Today
Sunday, March 28, 2010 - 1:15pm
tags:
Avid, Cardinal Health, Alzheimer's disease
Eisai Revenues Set to Fall Off the 'Patent Cliff' as Sepsis Drug Hits Delay
Seeking Alpha
Sunday, March 28, 2010 - 1:12pm
tags:
Eisai, Aricept, eritoran
New Insight Into Multiple-Sclerosis Treatment (beta -interferon)
Wall Street Journal
Sunday, March 28, 2010 - 1:11pm
tags:
multiple sclerosis, beta-interferon
Transcept Pharma receives US patent covering Intermezzo formulation
Pharmabiz
Saturday, March 27, 2010 - 11:45am
tags:
Intermezzo, Transcept, insomnia
Teva gets US FDA's tentative nod to market generic Argatrobar injection
Pharmabiz
Saturday, March 27, 2010 - 11:36am
tags:
Teva Pharmaceuticals, Argatrobar, anticoagulants
Eli Lilly Close to Resistance
Trader's Huddle
Saturday, March 27, 2010 - 11:31am
tags:
Eli Lilly
Dragon Pharma to go private for $0.82/shr
Reuters
Saturday, March 27, 2010 - 11:29am
tags:
Dragon Pharmaceutical
inVentiv Health Announces Approach From Financial Investors Regarding Possible Transaction
CNN Money
Saturday, March 27, 2010 - 11:28am
tags:
inVentiv, M&A
Thermo Fisher Scientific and Lilly Announce Expanded Clinical Trial Materials Relationship
Genetic Engineering and Biotechnology News
Saturday, March 27, 2010 - 11:27am
tags:
Eli Lilly, Thermo Fisher
Europe halts sale of Indian-sourced drug
Financial Times, UK
Saturday, March 27, 2010 - 11:24am
tags:
Acino, Glochem Industries
Orphan Drug Market Catches Pharma's Eye
Yahoo/Investor's Business Daily
Saturday, March 27, 2010 - 11:23am
tags:
orphan drugs, Novartis, Pfizer
What Do Pfizer and the Mafia Have in Common? (RICO action)
Motley Fool
Saturday, March 27, 2010 - 11:21am
tags:
Pfizer, legal
Keryx's Loss Wider than Expected
Yahoo/Zacks
Saturday, March 27, 2010 - 11:19am
tags:
Keryx
Corcept Posts Narrower Q4 Loss
Yahoo/Zacks
Saturday, March 27, 2010 - 11:18am
tags:
Corcept Therapeutics

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline
The GLP-1 Saga Continues, And How
In the Pipeline
Defluorination is Happening Inside You Right Now
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.